BioSpace News Archive

FDA

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-L301 Gene Therapy for Pyruvate Kinase Deficiency (PKD)

Rocket Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to RP-L301, the Company’s investigational lentiviral-based gene therapy for Pyruvate Kinase Deficiency (PKD).

May 23, 2023
·
9 min read
Business

Aurora Spine Corporation Schedules Release of First Quarter Fiscal Year 2023 Financial Results and Conference Call

Aurora Spine Corporation today announced it will issue its financial results press release for the first quarter fiscal 2023 ended March 31, 2023, on Wednesday, May 24, 2023.

May 23, 2023
·
3 min read
Biotech Bay

First ZAP-X Gyroscopic Radiosurgery Treatments Commence in France

ZAP Surgical Systems, Inc. today announced that Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France, has initiated patient treatments with the ground-breaking ZAP-X® Gyroscopic Radiosurgery® platform.

May 23, 2023
·
4 min read
Business

BrainsWay Announces Appointment of Ido Marom as CFO

BrainsWay Ltd. today announced the appointment of Ido Marom, an experienced senior financial leader in global industries, including medical technology, as Chief Financial Officer (CFO).

May 23, 2023
·
5 min read
Business

Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

Aclarion, Inc. announced that Dean Karahalios, M.D., Medical Director of Brain & Spine Institute at Advocate Aurora Health Care in Illinois, will advise the company as a key opinion leader nationally.

May 23, 2023
·
4 min read
Business

CalciMedica Expands Executive Team with New Appointments

CalciMedica Inc. today announced the appointments of Raven Jaeger, M.S., as Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, as Senior Vice President of Clinical Development.

May 23, 2023
·
5 min read
Drug Development

Arrowhead Presents Interim Data from ARO-ANG3 Phase 2 GATEWAY Study in Patients with HoFH

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented interim data from the ongoing Phase 2 GATEWAY clinical study of ARO-ANG3, the company’s investigational RNAi therapeutic designed to reduce expression of angiopoietin-like protein 3 (ANGPTL3), in patients with homozygous familial hypercholesterolemia (HoFH).

May 23, 2023
·
7 min read
Genetown

T2 Biosystems Announces Exploration of Strategic Alternatives and the Implementation of a Restructuring Program

T2 Biosystems, Inc. today announced it has initiated a process to explore a range of strategic alternatives focused on maximizing value.

May 23, 2023
·
4 min read
Business

Theriva Biologics Announces Appointment of Ramon Alemany, Ph.D., to Senior Vice President of Discovery

Theriva Biologics, a clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, announced the appointment of Dr. Ramon Alemany as Senior Vice President of Discovery, effective immediately.

May 23, 2023
·
8 min read
Drug Development

Cogent Biosciences to Host Investor Webcast to Discuss Lead-In Data Being Presented at ASCO from the Ongoing Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST)

Cogent Biosciences, Inc. today announced the details of its investor webcast being held Monday, June 5, 2023 at 8:00 a.m. ET (7:00 a.m. CT) to discuss lead-in data from its ongoing Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib in patients with Gastrointestinal Stromal Tumors (GIST).

May 23, 2023
·
2 min read